Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetes-Reference-Cited by-同舟云学术

Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetes

Published:2014-07-12 Issue:1 Volume:17 Page:15-22
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Home P. D.¹,Bolli G. B.²,Mathieu C.³,Deerochanawong C.⁴,Landgraf W.⁵,Candelas C.⁶,Pilorget V.⁶,Dain M.‐P.⁶,Riddle M. C.⁷

Affiliation:

1. Institute for Cellular Medicine – Diabetes Newcastle University Newcastle upon Tyne UK

2. Department of Medicine University of Perugia Perugia Italy

3. Department of Endocrinology University Hospital Gasthuisberg Leuven Belgium

4. Rajavithi Hospital, College of Medicine Rangsit University, Ministry of Public Health Bangkok Thailand

5. Sanofi Frankfurt Germany

6. Sanofi Paris France

7. Oregon Health & Science University Portland OR USA

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12329

Reference11 articles.

1. International Diabetes Federation. IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. International Diabetes Federation Web site.2012. Available from URL:https://www.aace.com/files/dm‐guidelines‐ccp.pdf. Accessed 3 April 2013.

2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

3. NICE. Blood‐glucose‐lowering therapy for type 2 diabetes. Available from URL:http://pathways.nice.org.uk/pathways/diabetes/blood‐glucose‐lowering‐therapy‐for‐type‐2‐diabetes. Accessed 6 December2013.

4. Business Information

5. A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2024-03-21

2. Use of basal insulin in the management of adults with type 2 diabetes: An Asia‐Pacific evidence‐based clinical practice guideline;Journal of Diabetes;2023-04-23

3. Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis;Journal of Diabetes;2023-04-10

4. Impact of the Fasting Plasma Glucose Titration Target on the Success of Basal Insulin Titration in Insulin-Naïve Patients with Type 2 Diabetes: A Systematic Analysis;Journal of Diabetes Research;2022-07-30

5. The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus;Journal of Pharmacy Technology;2021-11-10